Updated 06:11 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,883.00 +0.78% CL 84.99 -0.85% BTC 64,683.65 -0.95%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,883 +0.78% BTC $64,684 −0.95% VIX 22.91 +18.70% latest tape · as of 06:11 UTC
The Screen · Industrials

Experian

EXPN.L · LSE · GBp · Market cap $23.7B

FAIL · Does not pass the screen
2,967.00 GBp

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 06:11 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price2,967.00 GBp at the 13 Nov 2026 close
  • Fair value1,483.50. Our model only; no analyst estimate to cross-check.
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

FAIR-VALUE RANGE

Our fair-value range: range not available, base estimate 1,483.50 GBp (screen dated 2026-11-13).

Current read
Markup ?
Overvalued · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price2,967.00 GBp
Fair value1,483.50Our model only; no analyst estimate to cross-check.
Ethical score10.0/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-10-26Read Markup2,715.00+9.3% to today ✓Distribution gives way to Markup first Markup read since August
2026-10-02Read Distribution2,715.00+9.3% to today Markup gives way to Distribution first Distribution read since July
2026-07-28Read Markup2,616.00+13.4% to today ✓Distribution gives way to Markup
2026-07-02Read Distribution2,616.00+13.4% to today First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Experian holds its Markup at $2,967.00. Consolidating, no directional conviction, held for 19 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 19 days
Price at the screen$2,967.00
Valuation2,490.83 trailing · 1,825.05 forward price to earnings
Values screenFAIL · score 10.0
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio 38.9%

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 38.93% Below 33% Interest-bearing debt is 38.9% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 2.86% Below 33% Cash held in interest-bearing accounts and securities is 2.9% of assets, under the one-third limit. Pass
Receivables 13.07% Below 49% Money owed to the company is 13.1% of assets, under the 49% limit. Pass
Revenue purity 2.13% Below 5% Only 2.1% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Experian's business is in a permissible area, but its interest-bearing debt is about 39% of the company, just over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when EXPN.L's ethical verdict changes

Today EXPN.L does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our model only; no analyst estimate to cross-check.

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our 1,483.50 GBp fair value estimate, 12.20% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

1,483.50Conservative1,483.50Base case1,483.50Growth case 2,967.00Price

Fair value range in GBp, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 100.0% above the base estimate.

Projections

Where our models see it going: fair-value estimate 1,483.50 GBp, range not available, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it gives us pause

At 1,825.1x forward earnings, the price already runs ahead of the business. It trades 100% above our 1,483.50 GBp fair value, so you would be buying at a premium, not a discount.

The fundamentals · plain-English read
Forward P/E1,825.1xexpensive even after accounting for its growth
Trailing P/E2,490.8xexpensive: the price assumes strong growth ahead
EPS, trailing1.09
EPS, forward1.49
Revenue growth+12.2%steady growth
Profit margin0.0%currently unprofitable
Return on equity26.8%an exceptional return on shareholder capital
FCF yield5.55%
Dividend yield2.00%
Debt to equity1.05a meaningful debt load worth watching
Market cap$23.7B

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

EXPN.L trades on LSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-06 Markup $3,095.00 +14.0% Entry 9

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 14.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (18 analysts) rates it strong buy, with a mean price target of $3939.

2026-10-26 Markup · changed $2,715.00 +0.0% Entry 8

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (18 analysts) rates it strong buy, with a mean price target of $3939.

2026-10-17 Distribution $2,715.00 +0.0% Entry 7

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (18 analysts) rates it strong buy, with a mean price target of $3939.

2026-10-02 Distribution · changed $2,715.00 +3.8% Entry 6

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (18 analysts) rates it strong buy, with a mean price target of $3939. Since the last review it its composite score eased.

2026-08-28 Markup $2,616.00 +0.0% Entry 5

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (18 analysts) rates it strong buy, with a mean price target of $3939.

2026-07-28 Markup · changed $2,616.00 +0.0% Entry 4

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (18 analysts) rates it strong buy, with a mean price target of $3939.

2026-07-18 Distribution $2,616.00 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (18 analysts) rates it strong buy, with a mean price target of $3939.

2026-07-03 Distribution $2,616.00 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.

2026-07-02 Distribution $2,616.00 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · EXPN.L
DateInsiderTitleTypeSharesValue
2026-04-30 Experian plc 241,959 $8,825,454
2026-03-31 Experian plc · ·
2026-03-27 DeRose (Kathleen Traynor) 1,440 $48,916
2026-03-27 Lee (Esther) 4,500 $150,390
2026-03-25 DeRose (Kathleen Traynor) 1,750 $59,045
2026-02-27 Experian plc · ·
2026-02-19 Experian plc 398,957 $13,835,030
2026-02-18 Experian plc 399,760 $13,660,998
2026-02-17 Experian plc 400,000 $13,675,600
2026-02-16 Experian plc 400,000 $13,679,600

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $2,656.00 -3.8% · $962 -3.8%
2 months $2,568.50 -0.5% · $995 -0.5%
3 months $2,772.00 -7.8% · $922 -7.8%
6 months $3,311.85 -22.8% $15.88 $777 -22.3%
1 year $3,774.51 -32.3% $47.41 $690 -31.0%
2 years $3,649.05 -30.0% $95.23 $727 -27.3%
3 years $2,866.83 -10.8% $139.02 $940 -6.0%
5 years $2,712.10 -5.8% $217.95 $1,023 +2.3%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever EXPN.L does next, these words stay.

Experian · EXPN.L · Markup · $2,967.00
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.